Making MDT meetings more effective and safer with Salutare One Referral software
Single Cohort Before and After Mixed-methods Prospective Study to Investigate the Impact of the Salutare One Referral Software on Patient Outcomes, Safety and Effectiveness of Multi-Disciplinary Team (MDT) Meetings
This project will try the Salutare One Referral software with NHS MDT members and coordinators to see if it speeds up meetings and improves the information used for treating solid tumors and sarcoma.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Sex | All |
| Sponsor | Salutare Group Ltd. Industry-sponsored |
| Locations | 1 site (London) |
| Trial ID | NCT07104955 on ClinicalTrials.gov |
What this trial studies
Multi-Disciplinary Team (MDT) meetings are central to planning complex cancer care but can be slowed by incomplete information, repeated discussions, and administrative burden. This before-and-after study will observe MDT workflow without the software, then with Salutare One Referral in routine meetings, and then again without it to measure changes. MDT members and coordinators will complete questionnaires about feasibility, usability, and safety while the study analyses pseudonymized patient data to identify effects on decision-making and timeliness. The study focuses on implementation effectiveness, safety signals, and practical feasibility in an NHS specialist setting.
Who should consider this trial
Good fit: Ideal participants are MDT panel members, MDT coordinators, and clinical staff who prepare or submit MDT referrals at the participating NHS site.
Not a fit: Patients whose care is managed outside MDT processes or at hospitals not using this software are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, the software could enable faster, better-coordinated care and reduce delays in treatment planning for patients.
How similar studies have performed: Similar digital MDT and referral tools have shown small to moderate improvements in meeting efficiency in pilot implementations, but large-scale evidence of clinical or patient-outcome benefit is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals will take part in this study. Exclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals who are unwilling or unable to take part in the study.
Where this trial is running
London
- Royal National Orthopaedic Hospital — London, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Kevin Moore, MD — Salutare Limited
- Study coordinator: Liba Stones, MA, MBA
- Email: liba@dicro.co.uk
- Phone: +447443940319
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.